Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) insider Thomas E. Mazurek sold 4,285 shares of the business’s stock in a transaction on Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total value of $209,493.65. Following the completion of the transaction, the insider now directly owns 45,992 shares of the company’s stock, valued at $2,248,548.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Bath & Body Works Price Performance
BBWI stock traded up $0.57 during trading on Thursday, reaching $50.02. 2,257,412 shares of the stock traded hands, compared to its average volume of 2,789,631. The business’s 50 day moving average price is $45.05 and its 200-day moving average price is $38.74. Bath & Body Works, Inc. has a 52-week low of $27.30 and a 52-week high of $50.17. The firm has a market capitalization of $11.25 billion, a PE ratio of 12.84, a P/E/G ratio of 1.60 and a beta of 1.85.
Bath & Body Works (NYSE:BBWI – Get Free Report) last posted its quarterly earnings results on Thursday, February 29th. The company reported $2.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.21. The firm had revenue of $2.91 billion during the quarter, compared to the consensus estimate of $2.84 billion. Bath & Body Works had a negative return on equity of 37.01% and a net margin of 11.82%. The firm’s quarterly revenue was up .8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.86 earnings per share. On average, equities research analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.
Bath & Body Works Announces Dividend
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the stock. Shell Asset Management Co. lifted its stake in shares of Bath & Body Works by 180.0% during the third quarter. Shell Asset Management Co. now owns 56,344 shares of the company’s stock worth $1,904,000 after purchasing an additional 36,222 shares in the last quarter. Pearl River Capital LLC lifted its stake in shares of Bath & Body Works by 145.6% during the third quarter. Pearl River Capital LLC now owns 31,364 shares of the company’s stock worth $1,060,000 after purchasing an additional 18,596 shares in the last quarter. Aigen Investment Management LP acquired a new position in shares of Bath & Body Works during the third quarter worth about $1,697,000. Itau Unibanco Holding S.A. acquired a new position in shares of Bath & Body Works in the second quarter worth about $356,000. Finally, Vanguard Group Inc. lifted its stake in shares of Bath & Body Works by 0.3% in the third quarter. Vanguard Group Inc. now owns 25,689,543 shares of the company’s stock worth $868,307,000 after acquiring an additional 67,920 shares in the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities analysts have recently weighed in on BBWI shares. The Goldman Sachs Group boosted their price target on Bath & Body Works from $49.00 to $56.00 and gave the stock a “buy” rating in a report on Monday, March 4th. TD Cowen boosted their price target on Bath & Body Works from $35.00 to $55.00 and gave the stock an “outperform” rating in a report on Friday, March 1st. UBS Group boosted their price target on Bath & Body Works from $46.00 to $52.00 and gave the stock a “neutral” rating in a report on Monday, March 4th. Robert W. Baird lifted their price objective on Bath & Body Works from $50.00 to $54.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. Finally, Barclays downgraded Bath & Body Works from an “overweight” rating to an “equal weight” rating and lifted their price objective for the company from $37.00 to $45.00 in a research report on Thursday, January 4th. One analyst has rated the stock with a sell rating, seven have given a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $45.80.
View Our Latest Stock Report on Bath & Body Works
About Bath & Body Works
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Featured Stories
- Five stocks we like better than Bath & Body Works
- The How and Why of Investing in Gold Stocks
- 3 Value Stocks Too Small For Buffett’s Portfolio
- Bank Stocks – Best Bank Stocks to Invest In
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- What is a SEC Filing?
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.